BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$335M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$270M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$201M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$184M |
| 3 |
Amazon
AMZN
|
+$120M |
| 4 |
Johnson & Johnson
JNJ
|
+$101M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$80.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.62% |
| 2 | Financials | 5.87% |
| 3 | Communication Services | 5.36% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Healthcare | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTGE
2801
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $180K | ﹤0.01% |
10,028
-6,034
| -38% | -$107K |
|
2802
Evolent Health
EVH
$529M
| $179K | ﹤0.01% |
12,588
-2,513
| -17% | -$36K |
|
|
WRD
2803
DELISTED
WildHorse Resource Development
WRD
| $179K | ﹤0.01% |
9,383
-4,705
| -33% | -$83.9K |
|
|
EPZM
2804
DELISTED
Epizyme, Inc
EPZM
| $179K | ﹤0.01% |
10,088
+16
| +0.2% | +$270 |
|
2805
Univest Financial
UVSP
$1.19B
| $179K | ﹤0.01% |
6,461
-6,608
| -51% | -$185K |
|
2806
St. Joe Company
JOE
$3.89B
| $179K | ﹤0.01% |
9,491
-4,465
| -32% | -$82.7K |
|
2807
Cinemark Holdings
CNK
$4.33B
| $179K | ﹤0.01% |
4,747
-17,083
| -78% | -$649K |
|
2808
Pampa Energía
PAM
$4.23B
| $179K | ﹤0.01% |
2,996
+1,888
| +170% | +$123K |
|
2809
Sonic Automotive
SAH
$2.56B
| $179K | ﹤0.01% |
9,422
-2,103
| -18% | -$42.4K |
|
2810
Virtu Financial
VIRT
$5.3B
| $178K | ﹤0.01% |
5,404
+116
| +2% | +$3K |
|
2811
PUT
Marriott International
MAR
$93B
| $177K | ﹤0.01% |
+1,300
| New | +$182K |
|
|
BMTC
2812
DELISTED
Bryn Mawr Bank Corp
BMTC
| $177K | ﹤0.01% |
4,017
-1,436
| -26% | -$64.7K |
|
2813
Huron Consulting
HURN
$2.42B
| $176K | ﹤0.01% |
4,632
-2,253
| -33% | -$88.7K |
|
2814
Cabot Corp
CBT
$4.54B
| $176K | ﹤0.01% |
3,154
-10,930
| -78% | -$690K |
|
|
CRC
2815
DELISTED
California Resources Corporation
CRC
| $176K | ﹤0.01% |
10,245
-1,378
| -12% | -$25.9K |
|
2816
Griffon
GFF
$4.72B
| $176K | ﹤0.01% |
9,624
-2,783
| -22% | -$54.8K |
|
2817
Regenxbio
RGNX
$711M
| $175K | ﹤0.01% |
5,872
+261
| +5% | +$7.6K |
|
|
WEB
2818
DELISTED
Web.com Group, Inc.
WEB
| $175K | ﹤0.01% |
9,641
+1,529
| +19% | +$31.2K |
|
|
VSM
2819
DELISTED
Versum Materials, Inc.
VSM
| $174K | ﹤0.01% |
4,636
-17,984
| -80% | -$685K |
|
|
CARO
2820
DELISTED
Carolina Financial Corp.
CARO
| $174K | ﹤0.01% |
4,439
-2,553
| -37% | -$101K |
|
2821
Regis Corp
RGS
$69.3M
| $174K | ﹤0.01% |
576
-478
| -45% | -$151K |
|
2822
CytomX Therapeutics
CTMX
$732M
| $174K | ﹤0.01% |
6,121
+50
| +0.8% | +$1.43K |
|
2823
Triumph Financial Inc
TFIN
$1.87B
| $174K | ﹤0.01% |
4,222
-5,595
| -57% | -$219K |
|
2824
iShares MSCI Singapore ETF
EWS
$1.17B
| $173K | ﹤0.01% |
6,500
+6,335
| +3,839% | +$171K |
|
|
PGNX
2825
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $173K | ﹤0.01% |
23,222
-5,891
| -20% | -$39.2K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2018 Portfolio in Review
As of Q1 2018, BNP Paribas Financial Markets held 4,465 positions worth $53.4B, down 5.3% from $56.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.87B in Q1 2018, closing 241 positions and reducing 2,365 holdings. Its most notable exit was Calpine Corporation, an estimated $15.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 4.4% a quarter earlier, followed by Financials and Communication Services.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares Russell 2000 Growth ETF worth $95.3M.
- BNP Paribas Financial Markets's largest Q1 2018 buy was iShares Russell 2000 Growth ETF: 500,000 shares worth $95.3M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $1.69B increase.
- BNP Paribas Financial Markets's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $201M.
- BNP Paribas Financial Markets fully exited Calpine Corporation in Q1 2018, selling an estimated $15.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $53.4B portfolio in Q1 2018.
- BNP Paribas Financial Markets opened 229 new positions and closed 241 in Q1 2018.
- BNP Paribas Financial Markets's portfolio value fell 5.3% quarter-over-quarter to $53.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2018, filed 11 May 2018.